Multiple Sclerosis

Multiple Sclerosis Group Presentation Clin 213-50 Humber College Clin 213-50 Humber College Downloaded from www.jama.com

Introduction ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Overview ,[object Object],Clin 213-50 Humber College

Multiple Sclerosis - Introduction ,[object Object],[object Object],[object Object],[object Object],[object Object]

History of Multiple Sclerosis ,[object Object],[object Object],Clin 213-50 Humber College

Multiple Sclerosis - Epidemiology ,[object Object],[object Object],[object Object],[object Object]

World Distribution of MS Clin 213-50 Humber College

Multiple Sclerosis - Types ,[object Object],[object Object],[object Object],[object Object],[object Object]

Multiple Sclerosis - Types ,[object Object],[object Object],[object Object],[object Object]

Multiple Sclerosis Signs and Symptoms ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Multiple Sclerosis Signs and Symptoms ,[object Object],[object Object]

Factors Contributing for MS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Multiple Sclerosis - Causes ,[object Object],[object Object],[object Object]

Multiple Sclerosis - Diagnosis ,[object Object],[object Object],[object Object]

Possible v/s Definite MS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

MRI as Surrogate marker of disease process in MS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Multiple Sclerosis - Diagnosis ,[object Object],[object Object],[object Object],[object Object]

How Does it work? Clin 213-50 Humber College

Demyelination of Nerve Fibers in MS Clin 213-50 Humber College The destruction of the myelin sheath leads to impaired communication between nerve cells and neurological symptoms such as abnormal sensations, vision problems , and weakness

Mode of Action ,[object Object],Clin 213-50 Humber College

How Autoimmune response cause MS Clin 213-50 Humber College

Pathophysiology ,[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Clinical Tools for MS Diagnosis Schumacher Clinical Criteria -1965 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Clinical Tools for MS Diagnosis Poser Criteria for the 1983 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Clinical Tools for MS Diagnosis McDonald Criteria Clin 213-50 Humber College

Clinical Tools for MS Diagnosis Expanded Disability Status Scale ,[object Object],[object Object]

Clinical Tools for MS Diagnosis EDSS - Issues ,[object Object],[object Object],[object Object],[object Object],[object Object]

Clinical Tools for MS Diagnosis EDSS - Issues ,[object Object],[object Object],[object Object]

Clinical Tools for MS Diagnosis Multiple Sclerosis Functional Composite ,[object Object],[object Object]

Treatment of Multiple Sclerosis ,[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Treatments available in Canada ,[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Alternative Treatments ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Medications used for MS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Current Treatments Clin 213-50 Humber College ,[object Object],[object Object],[object Object],[object Object],[object Object]

Current Treatments Clin 213-50 Humber College ,[object Object],[object Object],[object Object]

C urrent treatments cont’d: Disease Modifying Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Current Treatments cont’d: INTRAMUSCULAR INTERFERON BETA-1aTHERAPY ( LAWRENCE,D. JACOBS et al, SEPTEMBER28, 2000) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Current Treatments cont’d: Alemtuzumab ,[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Antidepressants Efficacy Trial Michael A. Posternak, M.D. et al, (Am J Psychiatry 2002; 159:191 – 200) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Safety and Efficacy Issues ,[object Object],[object Object],[object Object]

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis ,[object Object],[object Object]

Nataluzimab: marketing withdrawal pending evaluation ,[object Object],[object Object],[object Object],[object Object]

Multiple Sclerosis and Epstein-Barr Virus Ref: Lynn I. Levin, PhD, MPH et al, JAMA . 2003;289(12):1533-1536 (doi:10.1001/jama.289.12.1533) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Research Themes for Multiple Sclerosis ,[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Focus on current trends ,[object Object],[object Object],[object Object]

Hookworms In MS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Stem Cells in Multiple Sclerosis ,[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Stem Cells in Multiple Sclerosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Stem Cells in Multiple Sclerosis ,[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Stem Cells in Multiple Sclerosis ,[object Object],[object Object],[object Object],Clin 213-50 Humber College

Stem Cells in Multiple Sclerosis ,[object Object],[object Object],Clin 213-50 Humber College

Stem Cells in Multiple Sclerosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Stem Cells in Multiple Sclerosis ,[object Object],Clin 213-50 Humber College

Vitamin D – the basics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Sources of Vitamin D ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Vitamin D and Multiple sclerosis ,[object Object],[object Object]

1. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis J. Nieves, F. Cosman, J. Herbert, V. Shen and R. Lindsay ,[object Object],[object Object],[object Object]

Neives et. Al cont’d ,[object Object]

Neives et. Al cont’d (Results) ,[object Object]

Neives et al. cont’d ,[object Object]

Cytokine Profile in Patients with Multiple Sclerosis Following Vitamin D Supplementation. B.D. Mahon, S. A. Gordon, J. Cruz, F. Cosman, and M.T. Cantorna ,[object Object]

Cytokine Profile in Patients with Multiple Sclerosis Following Vitamin D Supplementation. B.D. Mahon, S. A. Gordon, J. Cruz, F. Cosman, and M.T. Cantorna ,[object Object],[object Object]

Cytokine Profile in Patients with Multiple Sclerosis Following Vitamin D Supplementation. B.D. Mahon, S. A. Gordon, J. Cruz, F. Cosman, and M.T. Cantorna ,[object Object],[object Object],[object Object]

Cytokine Profile in Patients with Multiple Sclerosis Following Vitamin D Supplementation. B.D. Mahon, S. A. Gordon, J. Cruz, F. Cosman, and M.T. Cantorna

Conclusion (vitamin D) ,[object Object],[object Object],[object Object]

Issues with Trial Design: ,[object Object],[object Object]

Issues with Trial Design Cont’d: ,[object Object],[object Object]

Issues with Trial Design Cont’d: ,[object Object],[object Object],[object Object],[object Object]

Ethical Considerations: ,[object Object],[object Object],[object Object],[object Object]

Guidelines 2001: ,[object Object],[object Object],[object Object]

Six terms for Placebo-Controlled Trials ,[object Object],[object Object],[object Object]

Six terms for Placebo-Controlled Trials Cont’d ,[object Object],[object Object],[object Object]

Informed Consent ,[object Object],[object Object]

Conclusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Reference ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Clin 213-50 Humber College

Multiple Sclerosis

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Ähnlich wie Multiple Sclerosis

Ähnlich wie Multiple Sclerosis (20)

Mehr von Dr.RAJEEV KASHYAP

Mehr von Dr.RAJEEV KASHYAP (20)

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

Multiple Sclerosis